Business Wire

CA-TALKDESK

9.5.2024 07:01:35 CEST | Business Wire | Press release

Share
Talkdesk Hires Simon Horrocks as Asia-Pacific Leader to Turbocharge the Company’s Regional Growth as Artificial Intelligence Innovator

Talkdesk®, Inc., a global AI-powered contact center leader for enterprises of all sizes, today announced that Simon Horrocks has joined Talkdesk as the Asia-Pacific (APAC) leader to help drive the company’s ongoing growth and expansion as an artificial intelligence (AI) leader in customer experience (CX).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508118657/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Simon Horrocks, Vice President of APAC at Talkdesk (Photo: Business Wire)

Horrocks joins Talkdesk with over 30 years of sales experience managing teams for startups and large organizations in APAC. Based in Sydney, Australia, he is focused on go-to-market acceleration and business expansion for Talkdesk in Australia and New Zealand (ANZ) and Southeast Asia. Horrocks’ appointment further highlights the company’s commitment to being an AI-first CX leader in APAC, as Talkdesk finalizes plans for a regional cloud in Australia and additional regional expansion.

Horrocks joined Talkdesk from Harness.io, where he led the charge in the APAC market as the U.S.-based software delivery platform start-up looked to make its mark in the region. Previously, he worked with several leading and prominent technology companies in APAC, including, AppDynamics, Cisco, IBM, and ScienceLogic.

In addition to Horrocks’ hire, Talkdesk recently promoted Miles Ennis to global sales leader and announced Munil Shah as the company’s chief technology officer (CTO). The appointments follow recent news of Talkdesk launching several groundbreaking and industry-first generative artificial intelligence (GenAI) innovations in CX, including Talkdesk Ascend Connect, Talkdesk Autopilot for Banking, Talkdesk Autopilot for Retail, and Talkdesk Autopilot for Healthcare. Under these new leaders, Talkdesk will capitalize on an extensive global opportunity as companies look to the power of GenAI to help them innovate and expand their businesses, improve customer experiences, and streamline operations.

Talkdesk operates at the forefront of the CX industry, helping companies globally to benefit from a new era of automation and intelligence with contact center solutions powered by Talkdesk AI.

The company was named a Leader in the G2 Spring 2024 Grid® Report for Contact Center category with over 1,800 five-star reviews and ranked #1 in multiple categories, including Enterprise Results and Usability Index for Contact Center Workforce, based on customers’ authentic feedback. Most recently, TrustRadius recognized Talkdesk with 2024 Top Rated Awards for contact center, call center workforce optimization, call recording, and voice over Internet Protocol (VoIP).

Supporting Quotes

William Welch, president and chief operating officer of Talkdesk, said, “APAC is an important market for Talkdesk. With Simon in this critical leadership position in our sales organization, we can drive further growth and success in the region. GenAI offers unparalleled opportunities for companies to elevate customer experience, and Talkdesk will be able to help more organizations globally to reap the benefits.”

Simon Horrocks, vice president of APAC at Talkdesk, commented: “Talkdesk is at the forefront of GenAI innovations in the contact center at a time when businesses need to deliver seamless CX more than ever. Talkdesk is already used by some of the largest banks, e-tailers, and BPOs in APAC, and I’m honored to join the company at such an exciting time, to continue the company’s global expansion momentum.”

About Talkdesk

Talkdesk® is a global cloud contact center leader for enterprises of all sizes. Talkdesk CX Cloud and Industry Experience Clouds help enterprises deliver modern customer service their way. Our trusted, flexible, and innovative contact center platform leverages AI and automation to drive exceptional outcomes for their customers and improve the bottom line. Serving enterprise customers in over 100 countries, we partner with our customers to deliver continuous innovation and breakthrough results. Our unwavering commitment to doing what we say we will do and our investment in the highest levels of security and reliability for our products make us second to none in the industry. Improve customer experiences, increase efficiency, and grow revenue with Talkdesk, a cloud contact center platform built for your industry. Learn more and take a self-guided demo at www.talkdesk.com.

Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508118657/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EIG’s MidOcean Energy Announces Initial Equity Raise of $1.2 billion Versus $1.0 billion Cover17.3.2026 08:26:00 CET | Press release

MidOcean Energy (“MidOcean” or the “Company”), a liquefied natural gas (LNG) company formed and managed by EIG, today announced an equity capital raise of more than $1.2 billion. This equity raise includes: a $500 million commitment from Idemitsu Kosan, a highly respected global energy company with a long-standing presence across the energy value chain; and additional commitments of $790 million from both new and existing investors. This represents a significant milestone in MidOcean’s capital formation program and reflects continued interest from both new and existing investors in the Company’s strategy to seek to build a diversified, resilient, long-life global LNG platform. There is significant further momentum from additional investors currently in documentation. MidOcean will continue to raise capital, with a cumulative target of up to $2 billion from new investors. The Company has received substantial interest from investors seeking long-term exposure to the LNG sector, supported

RS2 Launches “Beyond by RS2” to Power the Next Generation of European Fintech17.3.2026 08:00:00 CET | Press release

RS2, a Tier-1 global provider of payment processing infrastructure and technology solutions, today announced the launch of Beyond by RS2, a new digital payments brand designed to help fintech companies, platforms, and payment providers rapidly launch card issuing and payment acceptance services across Europe. Built on RS2’s globally proven BankWORKS platform, Beyond by RS2 offers fintechs a comprehensive sponsored issuer and acquiring program, enabling partners to issue cards and process payments without needing their own banking license or direct card scheme membership. The program leverages RS2’s Electronic Money Institution (EMI) license in Germany and its principal membership with Visa and Mastercard, allowing fintech partners to operate under RS2’s regulated infrastructure while maintaining their own customer experience and brand. “Beyond by RS2 represents a major step in our strategy to enable innovation in payments,” said Radi El Haj, CEO, RS2. “Fintechs today want to build powe

Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G Nfl Blood Assay17.3.2026 07:00:00 CET | Press release

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Europe N.V. has obtained a CE Certificate of the Lumipulse G NfL Blood assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Neurofilament light chain (NfL) in plasma and serum. “While our assay menu already features many powerful disease-specific biomarkers, NfL marks a major breakthrough: our first CE-marked blood test that empowers clinicians with insights across a wide range of neurological disorders,” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “We are excited to bring this test to our customers, further expanding our comprehensive portfolio of fully automated neurological disease testing solutions on the LUMIPULSE G platform. We continue to partner with organizations and clinical experts across the wor

H2SITE Appoints Javier Cavada as New Chairman of the Board of Directors17.3.2026 07:00:00 CET | Press release

H2SITE, a technology company delivering hydrogen production and separation solutions, announces the appointment of Javier Cavada as the new Chairman of the Board of Directors. Javier joins H2SITE at a strategic phase of accelerated industrial deployment and scale-up of its hydrogen solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316654723/en/ With more than 25 years of international leadership in the energy and industrial sectors, Javier brings extensive experience in industrialising complex technologies, building high-performance organisations, and scaling large-scale energy platforms. He currently serves as President and Chief Executive Officer of Mitsubishi Power EMEA. His track record also includes serving as CEO and President of Highview Power, as well as spending 17 years at Wärtsilä Corporation, where he held senior executive roles including President of the Energy division and a member of the global Exec

AMWC 2026: Galderma Showcases Category‑leading Innovation With a Comprehensive Portfolio and Holistic, Future‑focused Aesthetic Strategies17.3.2026 07:00:00 CET | Press release

Galderma will present nine posters spanning its full aesthetics portfolio at AMWC 2026, highlighting the regenerative benefits of Sculptra®, the long-lasting efficacy of Restylane®, and the advanced clinical performance of Relfydess® (RelabotulinumtoxinA) 1-9 The data reinforce Galderma’s future-focused approach to innovation, addressing emerging patient needs from menopause‑related skin changes to rising interest in body injectables and regenerative treatments A series of symposia and Masterclasses will further highlight Galderma’s leadership in aesthetics, showcasing how the portfolio supports complex patient profiles and evolving global trends Galderma (SIX: GALD) will present nine abstracts at the Aesthetic & Anti‑Aging Medicine (AMWC) World Congress 2026 in Monaco, showcasing innovative and robust scientific data across its aesthetics portfolio, alongside three symposia, and multiple Masterclasses and Meet‑the‑Expert sessions, all highlighting the expanding benefits of Sculptra, R

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye